subunit RNA levels as a result of decreasing nAChR ABSTRACT: Neurally evoked muscle electrical subunit promoter activity. Finally, we show that this activity suppresses nicotinic acetylcholine receptor decreased promoter activity is mediated through the (nAChR) gene expression in extrajunctional domains same DNA sequences that control activity-dependent of adult muscle fibers. It has been proposed that this gene expression. Therefore, we propose that in rat regulation is mediated by calcium influx through voltmuscle, calcium release from the SR participates in age-dependent L-type calcium channels but bypasses coupling muscle depolarization to nAChR gene the sarcoplasmic reticulum in chick and mouse C2C12 expression. ᭧ 1998 John Wiley & Sons, Inc. J Neurobiol 35: 245-cells. Here we report that in rat muscle calcium influx 257, 1998 through L-type calcium channels preferentially reKeywords: muscle; nicotinic acetylcholine receptor; duced nAChR 1-subunit RNA via a post-transcripactivity-dependent gene expression; calcium; sarcotional mechanism. In contrast, calcium release from plasmic reticulum the sarcoplasmic reticulum (SR) suppressed nAChR
INTRODUCTION
, while the extrajunctional suppression of nAChR gene expression is mediated by nerve-induced musSynaptogenesis at the neuromuscular junction (NMJ) cle depolarization (Simon et al., 1992 ; Klarsfeld serves as an excellent system for studying how the and . presynaptic neuron can control postsynaptic gene expression. For example, muscle innervation results
The molecular mechanism by which muscle acin the repression of nAChR genes (abgd) in extrativity suppresses nAChR gene expression is not well junctional myonuclei and the induction of nAChR understood. However, it has been suspected that genes (ab1d) in endplate-associated myonuclei components of the signaling cascade that mediates (Klarsfeld et al., 1991; Sanes et al., 1991;  Simon excitation-contraction coupling may also particiet al., 1992; Gundersen et al., 1993; Hall and Sans, pate in coupling membrane depolarization to 1993). This latter induction seems to be mediated nAChR gene expression. Although early reports by nerve-derived ARIA (Sandrock et al., 1977) , a suggested that calcium released from the sarcoplasneuregulin (Falls et al., 1993) , that binds epidermal mic reticulum (SR) can suppress nAChR protein growth factor (EGF) -like receptors (Moscoso et levels (Birnbaum et al., 1980; Pezzementi and Schmidt, 1981) , more recent experiments suggest that calcium influx across the plasma membrane, Huang et al., 1994) . This result sug-
Cell Culture
gests that DNA sequences mediating activity-deRat primary muscle cells were isolated and cultured as pendent gene expression should also mediate the described previously (Chahine et al., 1993) . Cells were effects of calcium influx. Surprisingly, this was plated on 60-mm collagen-coated culture dishes at a dennever tested.
sity of 3 1 10 6 cells/mL. In general, these cells began Therefore, we examined the effect various calto fuse by day 4 postplating and plates became confluent cium-perturbing drugs had on nAChR RNA levels with contracting myotubes around day 6. At this time, and promoter activity in primary rat muscle cultures.
cells were maintained in medium containing tetrodotoxin
In contrast to that reported for chick muscle (Huang (3 mg/mL) to prevent myotube contraction. Cells were Huang and Schmidt, 1994) , calcium transfected on day 6 postplating and were treated with influx through L-type channels preferentially revarious calcium-perturbing drugs about 48 h later. Culduced rat nAChR 1-RNA via a post-transcriptional tures were also treated with cytosine arabinoside (3 mg/ mL) for 24-48 h beginning immediately after transfecmechanism. However, calcium release from the SR otides 0116 to /20 driving luciferase expression. The a-subunit promoter mutants Mp and Mb have been previously described (Piette et al., 1990) . Mutations were created by site-directed mutagenesis using oligonucleo-
MATERIALS AND METHODS
tide primers and confirmed by DNA sequencing. The CMVCAT, mouse g-, and rat d-and 1-promoter/lucifer-
RNA Isolation and RNase
ase expression vectors have been previously described Protection Assay (Gilmour et al., 1995; Walke et al., 1994 Walke et al., , 1996 . The rat d-promoter expression vector is a chimera containing the Total RNA was isolated using the method of Chirgwin et al. (1979) . Antisense RNA probes used to detect muscle rat d-promoter's 47-bp activity-dependent enhancer upstream the minimal enkephalin (MEK) promoter (Walke creatine kinase (MCK) and nAChR a, b, g, d, and 1-RNAs were described previously (Chahine et al., 1993 (Chahine et al., ). et al., 1996 . This construct is more active than that lacking the MEK sequences. The MEK promoter was not RNase protection assays were carried out as previously described (Walk et al., 1994; Saccomanno et al., 1992) . regulated by calcium (Walke et al., 1994) . CMVCAT was not influenced by ryanodine or (0)Bay K 8644 in The MCK probe was included in every RNase protection assay and served to normalize for different amounts of our muscle culture system (CAT activity ratio for ryanodine/control was 0.99 { 0.12 averaged over 30 experi-RNA in the various samples. The MCK RNA also serves to indicate if the cellular perturbations we imposed on ments; CAT activity ratio for Bay K 8644/control was 1.1 { 0.12 averaged over seven experiments) and therethe cultured muscle cells had a general effect on myogenic factor activity, since the MCK RNA is induced by fore used for normalization purposes. Myotube cultures were transfected using calcium phosphate DNA precipimyogenic factors upon muscle differentiation in a similar fashion as the nAChR genes. MCK RNA was not regutates as previously described by Chahine et al. (1992) . CMVCAT was used at 3 mg/plate and the various nAChR lated by any of the conditions employed in this report. RNase protection assays were repeated at least twice and wild-type and mutant expression vectors were used at 10-20 mg/plate. Total DNA was adjusted to 30 mg/plate quantitated by scanning densitometry. Specificity of protected bands was confirmed by hybridizing probes to using BSSK(/) (Stratagene) DNA. Luciferase and CAT assays were performed as previously described (Brasier tRNA, which resulted in no protected fragments on the gel. In addition, probe integrity was monitored by omitet al., 1989; Neumann et al., 1987 
Drugs and Reagents
Ryanodine, thapsigargin, dantrolene, and the (/) and (0) enantiomers of Bay K 8644 were purchased from RBI (Natick, MA). A23187 was obtained from Sigma (St. Louis, MO). Tetrodotoxin was purchased from Molecular Probes (Eugene, OR). Ryanodine was prepared fresh as either a 1-or 10-mM stock as described previously (Pezzementi and Schmidt, 1981) . Dantrolene and the (/) and (0) enantiamers of Bay K 8644 were prepared as 10-mM stocks in dimethyl sulfoxide (DMSO). Thapsigargin and A23187 were prepared as 1-mM stocks in DMSO.
RESULTS

Calcium-Dependent Regulation of nAChR RNA Levels
To determine if calcium influx across the plasma membrane and/or efflux from the SR could regulate nAChR expression, we assayed nAChR RNA levels in rat primary myotube cultures treated with various calcium-perturbing pharmacological reagents. Ryanodine and thapsigargin increases calcium efflux from the SR by activating the ryanodine receptor (Meissner, 1968; Buck, 1992) and inhibiting SR calcium transport ATPase activity (Sagara and Inesi, 1991) , respectively. In contrast, Bay K 8644 specifically acts on L-type calcium channels that control calcium influx across the plasma membrane Figure 1 Calcium-dependent regulation of nAChR (Smilowitz, 1988; Reuter et al., 1985) . We also RNA levels. Primary myotubes were treated with either used the calcium ionophore A23187, which is ex- the 1-RNA, we had previously shown that A23187-
The graphs are quantitation of multiple RNase protection assays. Quantitation of RNase resistant hybrids was permediated suppression required calcium influx from formed by scanning densitometry. nAChR RNA levels extracellular stores (Walke et al., 1994) . By using were normalized to MCK RNA levels to correct for difthe L-type calcium channel agonist (0)Bay K ferent RNA yields between the different samples. RNase 8644, we confirmed this result and showed that 1-protection assays were repeated at least twice with differ-RNA levels decreased approximately 75% by calent samples of muscle RNA. Error bars are { standard cium influx across the plasma membrane ( Fig. 1 ).
deviation.
In contrast, (0)Bay K 8644 had no effect on b-or g-RNA levels and reduced a-and d-RNA levels only by about 20% and 40%, respectively ( Fig. 1 ).
(ryanodine and thapsigargin) and was reduced by only 25-45%. We have assayed the response of In contrast to the relatively specific and dramatic action of (0)Bay K 8644 on the 1-RNA, ryanodine the a-subunit RNA to 1 mM ryanodine in over 10 independent experiments. Although ryanodine genand thapsigargin caused a decrease in all the nAChR RNAs (Fig. 1) . The degree of repression varied erally causes a 75-85% decrease (Figs. 1 and 2; see also Fig. 4 ) in a-RNA levels, we observed effects as from about 75-88% for the a-and g-RNAs to approximately 50% for the b-and d-RNAs. Interestsmall as 60% (see Fig. 7 ). Although we do not know the reason for this variability, it may reflect ingly the 1-RNA was least responsive to these drugs slight variations in our ryanodine stock solution Forty-eight-hour exposure to ryanodine resulted in a concentration-dependent decrease in nAChR proand/or the developmental stage of our primary muscle cultures. These changes in nAChR RNA levels moter activity (data shown for the 116-bp a-promoter) (Fig. 3) , similar to the response of the enin response to ryanodine and thapsigargin are similar to those previously documented for active and dogenous RNA. Maximal inhibition was observed inactive myotubes (Chahine et al., 1993) . at 1 mM ryanodine, which decreased a-promoter Ryanodine is unusual in that it stimulates calcium activity by approximately 66%, while 100 mM ryanrelease from the SR at concentrations around 0.1-odine had little effect (Fig. 3) . Also, 1 mM ryano-10 mM and begins to block the release of SR caldine suppressed expression from the 388-bp g-procium at concentrations above 10 mM (Meissner, moter (63% reduction), 102-bp d-promoter (72% 1968; Buck et al., 1992; Delbono and Chu, 1995) . reduction), and 5-kb 1-promoter (69% reduction). This concentration-dependent effect of ryanodine Within 6 h following exposure to 1 mM ryanoon calcium release was also reflected in a-and gdine, the a-promoter was already suppressed ap-RNA levels (Fig. 2) . In contrast, the 1-RNA reproximately 50% (Fig. 4, bottom) . However, we sponded similarly to low (1-mM) and high (100-did not detect a significant decrease in a-RNA until mM) concentrations of ryanodine (Fig. 2) , which 12 h after drug treatment (Fig. 4, top) . These results may indicate a nonspecific effect on this RNA.
are not surprising since transcriptional changes usuNonetheless, these experiments and others (Fig. 1) ally precede changes in RNA levels which are govconsistently revealed that ryanodine was less effecerned by both transcription and stability. tive at reducing 1-RNA levels compared to the other In contrast to ryanodine, (0)Bay K 8644 had nAChR RNAs.
only a small effect on nAChR a-promoter activity, resulting in approximately a 20-25% decrease after
Calcium Release from the SR
48 h (Fig. 5, top) . In addition, none of the other
Suppresses nAChR Gene Expression
nAChR promoters were regulated by (0)Bay K 8644 at concentrations ranging from 1 to 30 mM Transient transfection assays were used to examine the effect of ryanodine on nAChR promoter activity.
(data only shown for the 1-promoter) (Fig. 5, Fig. 6(A) ] partially influenced activity-dependent gene expression, while mutation of both sequences completely abrogated this regulation (Bessereau et al., 1994; Su et al., 1995) . Here, we show that both E-boxes must also be mutated to block the suppressive effects of ryanodine [ Fig. 6(B) ]. We had previously identified a 46-bp region of the g-subunit gene promoter (nucleotides 0114 to 0159) that is necessary for its suppression by muscle activity (Gilmour et al., 1995) . A minimal gpromoter construct, pX2BG76 [ Fig. 6(A) ], lacking residues 0114 to 0159 is not regulated by muscle activity. However, when nucleotides 0114 to 0159 are placed upstream of this minimal promoter (pX2BGE76) [ Fig. 6(A) ], activity-dependent expression is restored (Gilmour et al., 1995) . Likewise, pX2BGE76 promoter activity is suppressed by ryanodine, while pX2BG76 is not [ Fig. 6(B) ].
Finally, we had also previously reported the identification of a 47-bp enhancer (d 047/01) that is necessary and sufficient to mediate the effects of muscle activity on d-subunit gene expression (Walke et al., 1996) . This enhancer appears to be composed of three elements (SV, Sp, and E), each of which when mutated completely abrogates regulated expression in response to muscle activity (Walke et al., 1996) . Expression vectors were created in which the wild-type or mutant 47-bp enhancer were placed upstream of the minimal enkephalin (MEK) promoter (Walke et al., 1996) [ Fig. 6(A) ]. The MEK promoter is not regulated by calcium (Walke et al., 1994) or muscle activity (Walke et al., 1996) . The wild-type construct (d 047/01) showed approximately a 75% reduction in activity in response to ryanodine, while the various mutants (d 047/01 SV mut, Sp mut, and E mut) were insensitive to ryanodine [ Fig. 6(B) ].
We also tested these wild-type and mutated promoter constructs for responsiveness to thapsigargin. As reported for ryanodine, wild-type promoters were repressed by thapsigargin, while mutant promoters were not (L. Adams and D. Goldman, unpublished observation). Therefore, elements medi- ating nAChR promoter repression by calcium remediate activity-dependent expression of these genes. Therefore, we propose that in rat, SR calcium lease from the SR map to those that mediate activity-dependent expression.
is a source of cytoplasmic calcium that contributes to reduced nAChR gene expression in active compared to inactive muscle.
The Effects of Ryanodine on nAChR
The observation that activation of ryanodine re-
Gene Expression Are Blocked
ceptor calcium channels in the sarcoplasmic reticuby Dantrolene lum caused decreased nAChR gene transcription, while activation of sarcolemmal L-type calcium Dantrolene inhibits calcium release from the SR (Ellis and Carpenter, 1972; Nelson et al., 1996) . channels specifically affected 1-RNA expression post-transcriptionally, suggests that specific signalWe used this drug to determine whether we could suppress the effects of ryanodine on nAChR gene ing cascades are linked to specific channel types. However, we have not ruled out the possibility that expression. If ryanodine mediates its effects on nAChR expression by stimulating calcium release these two different calcium channels mediate their effects on nAChR gene expression by raising intrafrom the SR, then dantrolene should reduce this effect. However, if ryanodine mediated its effects cellular calcium to different levels. The idea of distinct signaling cascades being coupled to particular independently of calcium release from the SR, dantrolene might be observed to have little effect. calcium channels is not new. For example, calcium influx through NMDA receptors and L-type calcium Indeed, in the presence of dantrolene, myotubes exhibited a dramatically reduced ryanodine rechannels mediate their effects on c-fos promoter activity by activating distinct signaling pathways in sponse compared to myotubes that were not treated with dantrolene (Fig. 7) . Increasing amounts of neurons (Ghosh et al., 1994) . Therefore, we recognize the possibility that a dantrolene blocked the ryanodine-dependent suppression of nAChR RNA and promoter activity in specific source of intracellular calcium might play an important role in mediating activity-dependent a dose-dependent manner up to approximately 75% of control (Fig. 7) . In addition, dantrolene alone gene expression. Our results are surprising in light of recent studies indicating that calcium flux was able to modestly increase nAChR RNA and promoter activity by approximately 20% and 40%, through L-type channels, but not from SR stores, suppresses nAChR gene expression in chick and the respectively. In contrast, use of the L-type calcium channel antagonist (/)Bay K 8644 in place of danmouse muscle cell line C2C12 Huang et al., 1994) . The reasons for this trolene in the above experiments had no effect on nAChR gene expression (L. Adams and D. Goldapparent discrepancy are not known. However, it is possible that the rat and chick nAChR genes reman, unpublished observation). These experiments, along with the use of other SR-acting drugs such spond to calcium-dependent signaling emanating from different calcium sources. In addition, it as thapsigargin, support the idea that suppression of nAChR RNA and promoter activity by ryanodine should be kept in mind that the C2C12 cell line is a transformed muscle cell that may have acquired is largely a result of calcium release from the SR. However, we cannot rule out the possibility, albeit many changes leading to its transformed phenotype. Differences between this cell line and the primary remote, that dantrolene could increase nAChR RNA and promoter activity by another, unknown mecharat muscle cultures used in this study may include signaling cascades and SR development (Grassi et nism. al., 1994) . In fact, the observation that ryanodine was unable to block depolarization-triggered calcium release from the SR and the partial effective-
DISCUSSION
ness of dantrolene in C2C12 cells are consistent with this latter possibility. The major findings reported here are: (a) L-type channel agonist Bay K 8644 had no effect on RNase protection and transient transfection assays revealed a relatively robust effect of ryanonAChR promoter activity, yet specifically suppressed the nAChR 1-subunit RNA levels; (b) dine and thapsigargin on nAChR gene expression (Figs. 1, 4 , and 6). Our observation that in addition nAChR RNA levels and promoter activity are suppressed by treatment with drugs that have been demto decreasing a-, g-, and d-RNA and promoter activity ryanodine also suppressed 1-promoter activity onstrated to release calcium from the SR; and, finally, (c) nAChR promoter sequences mediating (69% reduction) is consistent with transgenic studies showing the 1-promoter is regulated by muscle this suppression map to those previously shown to (Piette et al., 1990) . gpX2BG169 contains a 150-bp g-promoter driving luciferase expression. gpX2BG76 is a minimal 57-bp g-promoter driving luciferase expression. gpP2BGE76 is a fusion construct in which g-promoter sequences 0159 to 0114 were ligated to gpX2BG76 (Gilmour et al., 1995) . d-47/01 contains the d-promoter muscle-specific, activitydependent enhancer upstream of the minimal enkephalin (MEK) promoter. Nucleotide changes in mutants SV, Sp, and E are indicated by arrows (see Walke et al., 1996, for 
details). (B)
The luciferase gene, placed under control of wild-type or mutated fragments of the nAChR a-, g-, and d-subunit gene promoters were transiently transfected into myotubes along with the CMVCAT vector (for normalization purposes). Cells were then treated with ryanodine (1 mM) or buffer for 48 h prior to harvesting for luciferase and CAT activity. activity in vivo (Gundersen, 1993) . However, beFinally, the modest effect of calcium influx on nAChR a-and d-RNAs may reflect a change in cause this promoter directs expression to the synapse and is less responsive to muscle activity than promoter activity that is compensated by an opposing change in RNA stability. This does not appear the other nAChR promoters, we suggest that other regulatory cascades may also contribute to 1-proto be likely, since the a-promoter was repressed by only 20-25% following 24-48 h of drug treatment, moter activity and RNA expression profiles. Indeed, it has recently been shown that the 1-gene is reguwhile the 550-bp d-promoter, like the 1-promoter, was not regulated by (0)Bay K 8644 (data not lated by a Ras-dependent signaling cascade (Tansey et al., 1996; Si et al., 1996) . shown). These data suggest a post-transcriptional mechanism of regulation of these RNAs by calcium In contrast to the relatively robust effect of ryanodine on nAChR RNA levels, (0)Bay K 8644 was influx. However, we cannot rule out the possibility that elements mediating a response to (0)Bay K more restricted in its effects, causing a large decrease in 1-RNA with somewhat lesser of an effect 8644 are not included in our 550-bp d-and 5 kb 1-promoter constructs. on the a-and d-RNAs (Fig. 1) . This may indicate that these latter RNAs are also regulated by a calMight treating muscle cells with calcium-perturbing agents for periods extending beyond a few cium influx-dependent signaling pathway. However, their responsiveness to this pathway may be hours cause such a large or long-lasting change in intracellular calcium that it results in nonspecific less than the 1-RNA owing to differences in their DNA/RNA calcium-responsive elements. Alternaeffects due to perturbation of multiple regulatory events? We do not think so, because our RNase tively, if calcium influx is large enough, it might begin to impinge upon signaling molecules that norprotection and transient transfection assays argue in favor of specificity. First, RNase protection assays mally respond to calcium changes occurring in close proximity to the SR, modestly activating its signalshowed only drugs (ryanodine and thapsigargin), stimulating release of calcium from the SR suppress ing cascade and resulting in a relatively modest RNA change. Similar arguments could also be apnAChR gene expression, while the L-type calcium channel activator specifically affected the adult-type plied to the relatively modest effect of ryanodine on 1-RNA expression. specific 1-RNA (Fig. 1) there is a characteristic ryanodine dose response that follows the effect of ryanodine on the ryanodine receptor (Meissner, 1968; Buck et al., 1992) (Figs.  2 and 3 ). Third, we were able to attenuate the effects of ryanodine on nAChR RNA and promoter activity by adding dantrolene (Fig. 7) , which inhibits calcium release from the SR. Fourth, time-course assays suggest the effect of ryanodine on nAChR promoter activity is already observable by 6 h after drug treatment (Fig. 4, bottom) . All these results argue for a specific action of ryanodine on nAChR gene expression via its effect on calcium release from the SR. Based on the results described above, and because calcium is released from the SR during muscle contraction, we propose that calcium release from the SR participates in coupling muscle depolarization to nAChR gene expression in rat. To support this contention, we determined if the same DNA regulatory elements mediating nAChR promoter activity in response to muscle depolarization also mediate the effects of ryanodine and thapsigargin. Indeed, for the a-, g-, and d-subunit gene promoters, where elements mediating activity-dependent expression were mapped, these same activity-dependent sequences were also necessary for regulation by ryanodine and thapsigargin ( Fig. 6 ; data shown only for ryanodine).
However, it should be noted that the 116-bp apromoter construct that was used in the above promoter study has been shown to be regulated by muscle activity in a muscle-specific fashion . In this case, transgenic animals harboring a 111-bp a-promoter driving CAT expression showed activity-dependent expression in tibialis and extensor digitorum longus muscle but no expression Figure 7 The effects of ryanodine on nAChR RNA in the soleus muscle. It was concluded that the lack and promoter activity are inhibited by dantrolene.
of activity-dependent expression in soleus muscle
